Neotrofin for Treatment of Chemotherapy-Induced Peripheral Neuropathy

Clinical trial NCT00041795 · COMPLETED

Trial details

NCT number: NCT00041795
Sponsor: NeoTherapeutics
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Peripheral Nervous System Diseases Chemotherapy-Induced Peripheral Neuropathy

Start date: 2002-01-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.